From: Trends in socioeconomic inequalities in cause-specific premature mortality in Belgium, 1998–2019
Period | ASMR (D1) | ASMR (D10) | Absolute difference | Relative difference | ASMR RATIO (95%CI) | p-value (ASMR RATIO) | |
---|---|---|---|---|---|---|---|
Premature mortality (women) | 1998–2003 | 413.95 (408.20-419.71) | 246.97 (241.43-252.51) | 166.98 | 67.61% | 1.68 (1.64–1.72) | < 0.001 |
2014–2019 | 349.91 (345.08-354.74) | 183.86 (178.50-189.21) | 166.02 | 90.31% | 1.90 (1.85–1.96) | < 0.001 | |
Absolute difference | -64.04 | -63.11 | |||||
Relative difference | -15.47 | -25.55% | |||||
Ischemic heart disease | 1998–2003 | 36.50 (34.72–38.29) | 21.20 (19.39–23.01) | 15.30 | 72.17% | 1.72 (1.57–1.88) | < 0.001 |
2014–2019 | 17.59 (16.40-18.78) | 5.72 (4.79–6.64) | 11.87 | 207.52% | 3.08 (2.67–3.55) | < 0.001 | |
Absolute difference | -18.91 | -15.48 | |||||
Relative difference | -51.8 | -73.0% | |||||
Neoplasm of digestive system | 1998–2003 | 32.40 (30.70–34.10) | 26.75 (24.72–28.77) | 5.65 | 21.12% | 1.21 (1.10–1.32) | < 0.001 |
2014–2019 | 30.77 (29.20-32.34) | 21.30 (19.52–23.08) | 9.47 | 44.46% | 1.44 (1.32–1.58) | < 0.001 | |
Absolute difference | -1.63 | -5.45 | |||||
Relative difference | -5.10 | -20.40% | |||||
Breast cancer | 1998–2003 | 29.64 (28.01–31.28) | 32.45 (30.30–34.60) | 2.81 | 8.65% | 0.91 (0.84–0.99) | < 0.001 |
2014–2019 | 22.65 (21.32–23.99) | 21.66 (19.88–23.44) | 0.99 | 4.57% | 1.05 (0.95–1.16) | < 0.001 | |
Absolute difference | -6.99 | -10.79 | |||||
Relative difference | -23.58 | -33.25% | |||||
Lung cancer | 1998–2003 | 22.79 (21.35–24.23) | 12.36 (11.00-13.73) | 10.43 | 84.39% | 1.84 (1.64–2.09) | < 0.001 |
2014–2019 | 32.35 (30.76–33.95) | 16.32 (14.78–17.86) | 16.03 | 98.22% | 1.98 (1.80–2.18) | < 0.001 | |
Absolute difference | 9.56 | 3.96 | |||||
Relative difference | 41.94% | 32.04% | |||||
Cerebrovascular heart disease (Stroke) | 1998–2003 | 23.97 (22.52–25.43) | 15.39 (13.84–16.93) | 8.58 | 55.75% | 1.84 (1.64–2.09) | < 0.001 |
2014–2019 | 14.17 (13.10-15.25) | 7.58 (6.46–8.69) | 6.59 | 86.95% | 1.98 (1.80–2.18) | < 0.001 | |
Absolute difference | -9.8 | -7.81 | |||||
Relative difference | -40.88 | -50.74% | |||||
Chronic lung disease (COPD + Asthma) | 1998–2003 | 18.99 (17.69–20.29) | 5.2 (4.27–6.14) | 13.79 | 265.19% | 3.65 (3.14–4.28) | < 0.001 |
2014–2019 | 22.05 (20.72–23.39) | 6.57 (5.55–7.59) | 15.48 | 235.61% | 3.36 (2.94–3.83) | < 0.001 | |
Absolute difference | 3.06 | 1.37 | |||||
Relative difference | 16.11% | 26.34% | |||||
Female genital organs cancer | 1998–2003 | 17.05 (15.81–18.29) | 14.69 (13.22–16.15) | 2.36 | 16.06% | 1.16 (1.03–1.28) | < 0.001 |
2014–2019 | 13.91 (12.87–14.96) | 9.91 (8.69–11.14) | 4 | 40.36% | 1.40 (1.22–1.61) | < 0.001 | |
Absolute difference | -3.14 | -4.78 | |||||
Relative difference | -18.42 | -32.53% | |||||
Chronic liver disease | 1998–2003 | 15.18 (13.99–16.37) | 4.59 (3.74–5.45) | 2.31 | 230.72% | 3.30 (2.80–3.85) | < 0.001 |
2014–2019 | 12.74 (11.74–13.73) | 5.02 (4.10–5.93) | 7.72 | 153.78% | 2.54 (2.16–2.98) | < 0.001 | |
Absolute difference | -2.44 | 0.43 | |||||
Relative difference | -16.07% | 9.37% | |||||
Intentional self-harm | 1998–2003 | 11.23 (10.24–12.21) | 6.02 (5.09–6.95) | 5.21 | 86.54% | 1.86 (1.58–2.22) | < 0.001 |
2014–2019 | 9.94 (9.09–10.79) | 8.35 (7.18–9.51) | 1.59 | 19.04% | 1.19 (1.02–1.39) | < 0.001 | |
Absolute difference | -1.29 | 2.33 | |||||
Relative difference | -11.48% | 38.70 | |||||
Influenza & Pneumonia | 1998–2003 | 8.16 (7.29–9.04) | 5.65 (4.62–6.67) | 2.51 | 44.43% | 1.45 (1.19–1.70) | < 0.001 |
2014–2019 | 6.57 (5.83–7.31) | 3.24 (2.45–4.02) | 3.33 | 102.78% | 2.0 (1.61–2.55) | < 0.001 | |
Absolute difference | -1.59 | -2.41 | |||||
Relative difference | -19.49 | -42.65% |